Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: oxyntomodulin long-acting - OPKO Health

Next Previous
X
Search
Drug Profile

Research programme: oxyntomodulin long-acting - OPKO Health

Alternative Names: Anti-obesity peptide - PROLOR Biotech; LA-Oxyntomodulin; Long-acting oxyntomodulin - PROLOR Biotech; MOD-1002; MOD-6030; MOD-630; OXY-CTP; OXY-RPEG

Latest Information Update: 02 Oct 2021

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator PROLOR Biotech
  • Developer OPKO Health
  • Class Anorectics; Antihyperglycaemics; Gastrointestinal hormones; Obesity therapies; Peptides
  • Mechanism of Action Glucagon receptor agonists; Glucagon-like peptide-1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Obesity; Type 2 diabetes mellitus

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Obesity in USA (Parenteral, Injection)
  • 04 Nov 2017 No recent reports of development identified for preclinical development in Type-2-diabetes-mellitus in USA (Parenteral, Injection)
  • 29 Aug 2013 PROLOR Biotech has been acquired by OPKO Health

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top